Patents Assigned to Valeant Pharmceuticals International, Inc.
  • Method for treating neovascularization
    Patent number: 8862224
    Abstract: The present invention describes an improved photodynamic treatment to treat subfoveal choroidal neovascularization (CNV).
    Type: Grant
    Filed: April 16, 2012
    Date of Patent: October 14, 2014
    Assignee: Valeant Pharmceuticals International, Inc.
    Inventor: Romulus Kimbro Brazzell